IMPACTO FINANCEIRO DA DOENÇA RENAL CRÔNICA NO SISTEMA ÚNICO DE SAÚDE EM MATO GROSSO (2020-2024)

Abstract

The costs of Renal Replacement Therapy (RRT) for patients with Chronic Kidney Disease (CKD) represent a significant management challenge for the Unified Health System. The objective is to analyze the financial impact of Chronic Kidney Disease on the costs of the Unified Health System and to outline the sociodemographic profile of patients in Mato Grosso, from 2020 to 2024. This is a descriptive, quantitative, and cross-sectional study, with secondary data extracted from the Outpatient Information System of the Unified Health System, regarding hemodialysis and arteriovenous fistula creation procedures. The results indicated a growing trend in the financial burden on public funds, with a 45% increase in total costs during the period. The analysis of follow-up time demonstrated that late diagnosis is the main financial driver; patients with more than one year of treatment represented a cost 74% higher (R$ 34 million) compared to new patients (R$ 19.5 million). The sociodemographic profile is predominantly male, with 55.23% of records under 60 years old, impacting the economically active population. The impact of the COVID-19 pandemic was also identified, which, as noted in previous studies, generated an increase in dialysis procedures in the state, explaining the peak in costs in 2022. The most critical finding was the failure in data recording, where the "unfilled" category represented 73% of the frequency and 74.2% of the costs. It is concluded that the financial impact of Chronic Kidney Disease in Mato Grosso is growing, driven by preventable diseases, Systemic Arterial Hypertension and Diabetes Mellitus, and aggravated by failures in information management. Improving Primary Health Care emerges as a fundamental measure to reduce future costs.